Title : Antimalarial drug mefloquine inhibits nuclear factor kappa B signaling and induces apoptosis in colorectal cancer cells.

Pub. Date : 2018 Apr

PMID : 29453896






4 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Antimalarial drug mefloquine inhibits nuclear factor kappa B signaling and induces apoptosis in colorectal cancer cells. Mefloquine nuclear factor of kappa light polypeptide gene enhancer in B cells 1, p105 Mus musculus
2 In the present study, we found that the widely used antimalarial drug mefloquine was a NF-kappaB inhibitor that blocked the activation of IkappaBalpha kinase, leading to reduction of IkappaBalpha degradation, decrease of p65 phosphorylation, and suppressed expression of NF-kappaB target genes in CRC cells. Mefloquine nuclear factor of kappa light polypeptide gene enhancer in B cells 1, p105 Mus musculus
3 In the present study, we found that the widely used antimalarial drug mefloquine was a NF-kappaB inhibitor that blocked the activation of IkappaBalpha kinase, leading to reduction of IkappaBalpha degradation, decrease of p65 phosphorylation, and suppressed expression of NF-kappaB target genes in CRC cells. Mefloquine nuclear factor of kappa light polypeptide gene enhancer in B cells 1, p105 Mus musculus
4 These results showed that mefloquine could exert antitumor action through inhibiting the NF-kappaB signaling pathway, and indicated that the antimalarial drug might be repurposed for anti-CRC therapy in the clinic as a single agent or in combination with other anticancer drugs. Mefloquine nuclear factor of kappa light polypeptide gene enhancer in B cells 1, p105 Mus musculus